S.R.Y. (Medical Services) LTD, Israel

Radio-Pharmaceutical. Lutetium [177Lu] Oxodotreotide 600 MBq/mL 7,400 MBq / 12.5 ml.
VIAL (sol. for IV infusion):1X 12.5 ml (7,400 MBq). Recomm. dose: 4  vials at interval  of 8 weeks between each, can be ext. to 16 weeks. See lit.
Tmt. of unresect. or metast., progr., well diff. (G1 and G2), somatost. recept-posit. gastroenteropancr. neuroendocr. tumors (GEP-NETs) in adults.
C/I: Hypersens. Pregnancy or susp. pregn.
Renal fail. (creatinine clear. <30 mL/min)